A new study shows that the TissueCypher Barrett's Esophagus test significantly improves management of patients by nearly doubling appropriate care escalation for those at high risk of progressing to esophageal cancer, while reducing overtreatment in low-risk patients. The test uses advanced molecular analysis to better predict which patients with non-dysplastic Barrett's esophagus will develop serious conditions, enabling earlier and more precise interventions. This advancement could lead to better patient outcomes and more efficient use of medical resources in managing Barrett's esophagus.
TissueCypher Barrett's Esophagus test is the subject, with Pluang market data providing context. For readers following the health sector, here is Pluang's market snapshot as of Sep 15, 2026 16:41 WIB: Of 91 priced US health stocks, 35 rose and 48 fell. Notable movers include ACB at USD 3.92 (+2.89%), ENVB at USD 1.46 (-2.67%), and INO at USD 1.21 (+2.54%).
On October 12, 2026, Tryg A/S shares began trading ex-dividend with a dividend payout of 2.15 Danish kroner per share. This means investors buying the stock from this date will not receive the upcoming dividend. The announcement follows Tryg's strong...
On October 12, 2026, Tryg A/S shares began trading ex-dividend with a dividend payout of DKK 2.15 per share. This means investors buying shares from this date will not receive the upcoming dividend. The announcement follows Tryg's strong interim resu...
Kosmos Energy announced it will release its third quarter 2026 financial results on November 2, 2026, before the UK market opens. The company will hold a conference call and webcast at 11:00 a.m. ET the same day, accessible via phone and online. This...
Pulsar Helium announced its development and financing strategy for a commercial-scale helium purification and liquefaction plant, along with a CO2 processing plant in Minnesota, totaling $85.5 million in equipment costs. The company aims to fund the ...
BTS Group AB has acquired Edward Lynx AB, a Stockholm-based firm specializing in executive and senior leadership assessment and development. This acquisition strengthens BTS's Talent Insight and Assessment offerings and will be earnings accretive. Ed...
